Malaria, caused mostly by Plasmodium falciparum and P. vivax, remains one of the most important infectious diseases in the world. Antimalarial drug toxicity is one side of the risk-benefit equation and is viewed differently depending upon whether the clinical indication for drug administration is malaria treatment or prophylaxis. Drug toxicity must be acceptable to patients and cause less harm than the disease itself. Research that leads to drug registration tends to omit two important groups...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Antimalarial drug toxicity: a review.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record